HR021618
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
May 15, 2025
HR021618 in Moderate to Severe Pain After Abdominal Surgery
(clinicaltrials.gov)
- P2 | N=60 | Completed | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Active, not recruiting ➔ Completed
Trial completion • Pain
August 06, 2021
A Trial of HR021618 in Postsurgical Pain Management
(clinicaltrials.gov)
- P2; N=108; Active, not recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.; Recruiting ➔ Active, not recruiting
Enrollment closed • Orthopedics • Pain
July 01, 2021
HR021618 in Moderate to Severe Pain After Abdominal Surgery
(clinicaltrials.gov)
- P2; N=60; Active, not recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.; Recruiting ➔ Active, not recruiting
Clinical • Enrollment closed • Pain
June 23, 2021
HR021618 in Moderate to Severe Pain After Abdominal Surgery
(clinicaltrials.gov)
- P2; N=60; Recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Pain
March 23, 2021
HR021618 in Moderate to Severe Pain After Abdominal Surgery
(clinicaltrials.gov)
- P2; N=60; Not yet recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Clinical • New P2 trial • Pain
January 07, 2021
A Trial of HR021618 in Postsurgical Pain Management
(clinicaltrials.gov)
- P2; N=108; Recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Clinical • New P2 trial • Orthopedics • Pain
1 to 6
Of
6
Go to page
1